Back to results
US 2014/0228412 A1Published application
Apoptosis signal-regulating kinase inhibitor
AssigneeGilead Sciences, Inc.
InventorGregory Notte
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Claims17
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating a disease comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula (I)
- or a pharmaceutically acceptable salt thereof.
A method of treating a disease comprising administering to a patient in need thereof a pharmaceutical composition comprising a compound of formula (I)
Dependencies are inferred from the claim text.